Literature DB >> 16965361

Mycobacterial codon optimization of the gene encoding the Sm14 antigen of Schistosoma mansoni in recombinant Mycobacterium bovis Bacille Calmette-Guérin enhances protein expression but not protection against cercarial challenge in mice.

Paula B Varaldo1, Eliane N Miyaji, Monica M Vilar, Adriano S Campos, Waldely O Dias, Geraldo R G Armôa, Miriam Tendler, Luciana C C Leite, Douglas McIntosh.   

Abstract

A mycobacterial codon-optimized gene encoding the Sm14 antigen of Schistosoma mansoni was generated using oligonucleotide assembly. This synthetic gene enhanced approximately fourfold the protein expression level in recombinant Mycobacterium bovis Bacille Calmette-Guérin (rBCG) when compared to that obtained using the native gene in the same expression vector. Immunization of mice with rBCG expressing Sm14 via the synthetic gene induced specific cellular Th1-predominant immune responses, as determined by interferon-gamma production of Sm14-stimulated splenocytes, which were comparable to those recorded in animals immunized with an rBCG strain expressing the native gene. Administration of a single dose of the rBCG-Sm14 construct carrying the synthetic gene conferred protection against cercarial challenge in outbred Swiss mice, at a level equivalent to those provided by either a single dose of rBCG expressing the native gene or three doses of Escherichia coli-derived recombinant Sm14. Our data demonstrated that despite improving the level of antigen expression, the codon optimization strategy did not result in enhanced immunity or protection against cercarial S. mansoni challenge.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16965361     DOI: 10.1111/j.1574-695X.2006.00133.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  6 in total

Review 1.  Current status of vaccines for schistosomiasis.

Authors:  Donald P McManus; Alex Loukas
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

2.  Functional expression of the Flp recombinase in Mycobacterium bovis BCG.

Authors:  Houhui Song; Michael Niederweis
Journal:  Gene       Date:  2007-05-21       Impact factor: 3.688

Review 3.  The future of human DNA vaccines.

Authors:  Lei Li; Fadi Saade; Nikolai Petrovsky
Journal:  J Biotechnol       Date:  2012-09-07       Impact factor: 3.307

Review 4.  Molecular mechanisms for enhanced DNA vaccine immunogenicity.

Authors:  Lei Li; Nikolai Petrovsky
Journal:  Expert Rev Vaccines       Date:  2015-12-28       Impact factor: 5.217

Review 5.  Development of the Brazilian Anti Schistosomiasis Vaccine Based on the Recombinant Fatty Acid Binding Protein Sm14 Plus GLA-SE Adjuvant.

Authors:  Miriam Tendler; Marilia Almeida; Andrew Simpson
Journal:  Front Immunol       Date:  2015-05-12       Impact factor: 7.561

6.  New Recombinant Mycobacterium bovis BCG Expression Vectors: Improving Genetic Control over Mycobacterial Promoters.

Authors:  Alex I Kanno; Cibelly Goulart; Henrique K Rofatto; Sergio C Oliveira; Luciana C C Leite; Johnjoe McFadden
Journal:  Appl Environ Microbiol       Date:  2016-04-04       Impact factor: 4.792

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.